hVIVO Past Earnings Performance

Past criteria checks 6/6

hVIVO has been growing earnings at an average annual rate of 77.9%, while the Life Sciences industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 37.7% per year. hVIVO's return on equity is 45.4%, and it has net margins of 26%.

Key information

77.9%

Earnings growth rate

86.0%

EPS growth rate

Life Sciences Industry Growth21.5%
Revenue growth rate37.7%
Return on equity45.4%
Net Margin26.0%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How hVIVO makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:OPOR.F Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24671700
31 Mar 24631700
31 Dec 23591600
30 Sep 2360900
30 Jun 2360300
31 Mar 2356100
31 Dec 2251-100
30 Sep 2243-100
30 Jun 2235-100
31 Mar 2237-100
31 Dec 2139000
30 Sep 2139-210
30 Jun 2139-310
31 Mar 2130-710
31 Dec 2022-1120
30 Sep 2016-1110
30 Jun 2010-1110
31 Mar 207-800
31 Dec 193-600
30 Jun 190-200
31 Mar 190-100

Quality Earnings: OPOR.F has high quality earnings.

Growing Profit Margin: OPOR.F's current net profit margins (26%) are higher than last year (4.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: OPOR.F has become profitable over the past 5 years, growing earnings by 77.9% per year.

Accelerating Growth: OPOR.F's earnings growth over the past year (506.8%) exceeds its 5-year average (77.9% per year).

Earnings vs Industry: OPOR.F earnings growth over the past year (506.8%) exceeded the Life Sciences industry -4.7%.


Return on Equity

High ROE: OPOR.F's Return on Equity (45.4%) is considered outstanding.


Return on Assets


Return on Capital Employed


Discover strong past performing companies